🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Turkey / NCT06687317
Starting soon Observational

Reliabılıty,Validity Of The Turkish Version Of The KNAP

NCT06687317 · tracked via the Priya Life Science Turkey tracker
Sponsor
Gazi University
Phase
Observational
Started
2024-12-01
Last updated
2024-11-13

Condition(s) studied

Other

Investigational drug(s) / intervention(s)

Behavioral

Behavioral: KNAP

Study summary

This study, we performed the Turkish version validity and reliability of the KNAP

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: Physiotherapy and rehabilitation department students and physiotherapists who speak Turkish - Exclusion Criteria: Physiotherapy and rehabilitation students and physiotherapists who do not speak Turkish. \-

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Gokhan MARAS Ankara Turkey (Türkiye)
Gökhan maraş Ankara Turkey (Türkiye)

More Gazi University trials in Turkey

Acute Hemodynamic Responses to Blood Flow Restriction Aerobic Exercise in Interstitial Lung Disease Active, not recruiting
Myofascial Release Technique in Women With Primary Dysmenorrhea Recruiting
Impact of Smoking on Immune Responses in Peri-implant Health and Disease Recruiting
Effect of Visual Biofeedback-Assisted Oropharyngeal Exercises in Post-Stroke Dysphagia Recruiting
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06687317 on ClinicalTrials.gov ↗ ← All trials in Turkey